Skip to main content

Table 5 The resistance of Mtb isolated in China to first-line drugs and FQsa

From: Persistently high prevalence of primary resistance and multidrug resistance of tuberculosis in Heilongjiang Province, China

Location (Ref.)

Sampling

Year

Sampling sourceb

Sample

size

First-line Resistance (%)

MDR rate (%)

FQ Resistance (%)c

Total

New

Total

New

Total

MDR

China [1, 27, 28]

2007

Survey

3929

38.3

34.2

10.2

5.7

  
 

2007–2008

Survey

3634

  

9.9

 

4.0

 
 

2005–2012

Hospital

450

54.4

44.7

25.8

14.5

  

Jilin [29]

2008–2011

Survey

1772

40.1

33.1

13.5

8.60

  

Ningxia [30]

2013–2014

Survey

665

26.6

20.2

7.8

   

Chongqing [31]

2009–2013

Hospital

2271

61.9

52.9

26.3

16.7

  

Lianyungang, Jiangsu [32]

2011–2012

Survey

1012

30.4

23.4

8.7

4.2

  

Kaohsiung, Taiwan [33]

2000–2008

Hospital

421

15.2

 

2.1

   

Beijing [34]

2007–2009

Hospital

967

70.1

60.9

19.4

14.9

27.1

35.1

Xinjiang [35, 36]

2009–2013

Hospital

410

  

13.2

12.9

  

Heilongjiang (present)

2007–2012

Hospital

1427

57.0

48.7

22.8

13.6

  
 

2007–2009

Hospital

821

61.9

60.0

26.2

16.5

  
 

2010–2012

Hospital

606

50.5

41.9

18.2

9.9

10.4

25.0

Kunming, Yunnan [37]

2008–2009

CDC

279

31.5

 

9.3

   

Hunan [38]

2009–2010

Hospital

171

40.9

19.6

25.2

6.2

10.5

 

Xuzhou, Jiangsu [39]

2011–2012

Hospital

287

16.0

 

3.14

   

Zhejiang [40]

2011–2012

Hospital

1363

  

16.7

   

Rural China [10]

2008

Hospital

380

31.1

25.9

11.3

9.0

10.8

23.3

Jiangxi [41]

2010–2011

Hospital

804

  

19.8

   

Northeast China [42]

2010–2011

Hospital

205

26.3

22.0

6.8

3.0

  

Anhui [43]

2010–2011

Hospital

420

29.1

17.1

14.5

6.8

13.3

14.8

Shenzhen [44]

2009

Hospital

589

38.0

 

9.3

 

6.8

47.3

Chongqing [45]

2011–2013

Hospital

1976

  

10.5

  

24.5

Fujian [46]

2010–2011

Survey

1389

  

5.4

 

2.3

25.3

  1. a Mtb M. tuberculosis, MDR multidrug resistance, CDC Chinese Centre for Disease Control and Prevention, FQs fluoroquinolones
  2. bData was derived based on sampling sources of hospital (Hospital), local TB control system (CDC) or nationwide random survey
  3. cThe data presented the resistance rate of FQ-resistant from total or from MDR Mtb isolates examined (resistant to Ofloxacin, in Italian; resistant to levofloxacin, underlined)